Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins
Código 293625 (Harmonized System 2012 by 6 digits)
2023: US$8.28M, Total Trade Exchange
2023: US$525k, International Sales
2023: US$7.76M, International Purchases
Código 293625 (Harmonized System 2012 by 6 digits)
2023: US$8.28M, Total Trade Exchange
2023: US$525k, International Sales
2023: US$7.76M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins was US$8.28M.
In 2019, the states with the most international sales in Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were Jalisco (US$309k).
The states with the most international purchases in 2023 were Jalisco (US$6.02M), Ciudad de México (US$227k), Estado de México (US$113k), and Baja California (US$12k).
In 2019, the main commercial destinations of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were Guatemala (US$164k), Brazil (US$71.9k), Dominican Republic (US$40.4k), Costa Rica (US$18.9k), and United States (US$10.1k).
The main commercial origins of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins in 2023 were Germany (US$4.37M), China (US$2M), United States (US$6.88k), Japan (US$1.99k), and Switzerland (US$202).
In the global context, the main exporting countries of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins in 2022 were China (US$187M), Netherlands (US$49.1M), and Germany (US$37.9M). In the same year, the main importing countries of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were United States (US$44.6M), Netherlands (US$42.1M), and Germany (US$14.9M).
US$8.28M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins in Mexico (including international purchases and sales) was US$8.28M.
The visualizations show the net balance of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024
In November 2024, international sales of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were US$42.5k, while international purchases reached US$661k. The above results in a trade balance of -US$619k.
Jalisco: US$309k, State with the Most International Sales (2019)
Guatemala: US$164k, Main commercial destination (2019)
In 2019, the states with the highest international sales in Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were Jalisco (US$309k).
In 2019, the countries with the most international purchases from Mexico were Guatemala (US$164k), Brazil (US$71.9k), Dominican Republic (US$40.4k), Costa Rica (US$18.9k), and United States (US$10.1k).
Jalisco: US$6.02M, State with the Most International Purchases (2023)
Germany: US$4.37M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were Jalisco (US$6.02M), Ciudad de México (US$227k), Estado de México (US$113k), and Baja California (US$12k).
The countries with the most international sales to Mexico in 2023 were Germany (US$4.37M), China (US$2M), United States (US$6.88k), Japan (US$1.99k), and Switzerland (US$202).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were China (US$187M), Netherlands (US$49.1M), and Germany (US$37.9M). In the same year, the main importing countries for Vitamin B6 and Derivatives Thereof Used Primarily as Vitamins were United States (US$44.6M), Netherlands (US$42.1M), and Germany (US$14.9M).